New antibiotics

Related Experiment Video

Updated: Oct 30, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

I R Friedland1, I Lutsar

  • 1Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235-9063, USA.

Current Opinion in Pediatrics
|April 8, 1998
PubMed

Insights

This review covers three broad-spectrum antibiotics: meropenem, cefepime, and trovafloxacin. These powerful antibacterial agents are best reserved for severe infections, particularly in immunocompromised patients.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • Review of three distinct classes of broad-spectrum antibiotics.
  • Focus on meropenem, cefepime, and trovafloxacin for treating serious bacterial infections.

Purpose of the Study:

  • To compare the characteristics and clinical applications of meropenem, cefepime, and trovafloxacin.
  • To highlight the advantages and limitations of each antibiotic in pediatric and adult populations.

Main Methods:

  • Literature review of pharmacological properties and clinical trial data.
  • Comparative analysis of antibacterial spectrum, efficacy, and safety profiles.

Main Results:

  • Meropenem shows improved gram-negative activity and reduced seizure risk compared to imipenem, approved for children.
  • Cefepime (fourth-generation cephalosporin) offers broad gram-positive and gram-negative coverage, approved for adults.
  • Trovafloxacin (fluoroquinolone) possesses an exceptionally wide antibacterial spectrum but is still in clinical trials.

Conclusions:

  • Meropenem, cefepime, and trovafloxacin represent significant advancements in treating serious infections.
  • Judicious use is recommended, especially for immunocompromised patients and polymicrobial infections.
  • Availability and approval status vary, impacting clinical decision-making.

More Related Videos

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Assay Development for High-Throughput Drug Screening Against Mycobacteria07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...